Co-Authors
This is a "connection" page, showing publications co-authored by VICKIE R SHANNON and AJAY SHESHADRI.
Connection Strength
2.220
-
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. Oncologist. 2023 Nov 02; 28(11):e1065-e1074.
Score: 0.242
-
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Front Immunol. 2023; 14:1249511.
Score: 0.241
-
Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study. Cancer Med. 2023 09; 12(17):17753-17765.
Score: 0.239
-
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature. J Immunother Precis Oncol. 2023 May; 6(2):111-116.
Score: 0.232
-
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study. Cancer. 2022 07 15; 128(14):2736-2745.
Score: 0.218
-
Pulmonary Function Testing in Patients with Tracheostomies: Feasibility and Technical Considerations. Lung. 2021 06; 199(3):307-310.
Score: 0.202
-
Pulmonary Toxicities of Immunotherapy. Adv Exp Med Biol. 2021; 1342:357-375.
Score: 0.199
-
Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2020; 1244:255-269.
Score: 0.186
-
Immune-Related Adverse Events: Pneumonitis. Adv Exp Med Biol. 2018; 995:131-149.
Score: 0.162
-
Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis. 2023 11 28; 228(11):1549-1558.
Score: 0.061
-
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications. Front Immunol. 2020; 11:590494.
Score: 0.050
-
Complications following symptom-limited thoracentesis using suction. Eur Respir J. 2020 11; 56(5).
Score: 0.049
-
Role of Infliximab in Immune Checkpoint Inhibitor-Induced Pneumonitis. J Immunother Precis Oncol. 2020 Nov; 3(4):172-174.
Score: 0.049
-
Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory Study. J Bronchology Interv Pulmonol. 2020 Jan; 27(1):4-13.
Score: 0.046
-
Routine Microbiologic Studies of Pleural Fluid Specimens in Cancer Patients. Am J Med. 2020 02; 133(2):240-244.
Score: 0.045